|
|
||||||||
The FASEB Journal, Vol 8, 479-488, Copyright © 1994 by The Federation of American Societies for Experimental Biology
REVIEWS |
TT Yen, AM Gill, LG Frigeri, GS Barsh and GL Wolff
Lilly Research Laboratories, Eli Lilly & Co., Lilly Corporate Center, Indianapolis, Indiana 46285.
The viable yellow A(vy) mutation results in a mottled yellow mouse that is obese, slightly larger than its nonyellow sibs, and more susceptible to tumor formation in those tissues sensitized by the strain genome. The mutation exhibits variable expressivity resulting in a continuum of coat color phenotypes, from clear yellow to pseudoagouti. The mouse agouti protein is a paracrine signaling molecule that induces hair follicle melanocytes to switch from the synthesis of black pigment to yellow pigment. Molecular cloning studies indicate that the obesity and growth effects of the A(vy) mutation result from ectopic expression of the normal agouti gene product. This review seeks to summarize the current state of knowledge regarding the obesity, stimulation of somatic growth, and enhancement of tumor formation caused by the A(vy) mutation, and to interpret these pleiotropic effects in terms of the normal function of the agouti protein.
This article has been cited by other articles:
![]() |
M. B. Zemel and X. Sun Dietary Calcium and Dairy Products Modulate Oxidative and Inflammatory Stress in Mice and Humans J. Nutr., June 1, 2008; 138(6): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. Bera, X.-F. Liu, M. Yamada, O. Gavrilova, E. Mezey, L. Tessarollo, M. Anver, Y. Hahn, B. Lee, and I. Pastan A model for obesity and gigantism due to disruption of the Ankrd26 gene PNAS, January 8, 2008; 105(1): 270 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Czyzyk, M. A. Sikorski, L. Yang, and G. S. McKnight Disruption of the RII subunit of PKA reverses the obesity syndrome of agouti lethal yellow mice PNAS, January 8, 2008; 105(1): 276 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. J. Ellacott, J. G. Murphy, D. L. Marks, and R. D. Cone Obesity-Induced Inflammation in White Adipose Tissue Is Attenuated by Loss of Melanocortin-3 Receptor Signaling Endocrinology, December 1, 2007; 148(12): 6186 - 6194. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Karnik, H. Chen, G. W. McLean, J. J. Heit, X. Gu, A. Y. Zhang, M. Fontaine, M. H. Yen, and S. K. Kim Menin Controls Growth of Pancreatic {beta}-Cells in Pregnant Mice and Promotes Gestational Diabetes Mellitus Science, November 2, 2007; 318(5851): 806 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Coenen and A. H. Hasty Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E492 - E499. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Wright, K. A. Longo, V. W. Dolinsky, I. Gerin, S. Kang, C. N. Bennett, S.-H. Chiang, T. C. Prestwich, C. Gress, C. F. Burant, et al. Wnt10b Inhibits Obesity in ob/ob and Agouti Mice Diabetes, February 1, 2007; 56(2): 295 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Cone Studies on the Physiological Functions of the Melanocortin System Endocr. Rev., December 1, 2006; 27(7): 736 - 749. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Kublaoui, J. L. Holder Jr., K. P. Tolson, T. Gemelli, and A. R. Zinn SIM1 Overexpression Partially Rescues Agouti Yellow and Diet-Induced Obesity by Normalizing Food Intake Endocrinology, October 1, 2006; 147(10): 4542 - 4549. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. K. Phan, W. K. Chung, and R. L. Leibel The mahoganoid mutation (Mgrn1md) improves insulin sensitivity in mice with mutations in the melanocortin signaling pathway independently of effects on adiposity Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E611 - E620. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakayama and T. Ishida Alu-mediated 100-kb deletion in the primate genome: The loss of the agouti signaling protein gene in the lesser apes. Genome Res., April 1, 2006; 16(4): 485 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Smith, P. B. Patil, S. D. Minteer, J. R. Lipsitz, and J. S. Fisher Possibility of Autocrine {beta}-Adrenergic Signaling in C2C12 Myotubes Experimental Biology and Medicine, December 1, 2005; 230(11): 845 - 852. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-Y. J. Lam, K. K. Youngren, and J. H. Nadeau Enhancers and Suppressors of Testicular Cancer Susceptibility in Single- and Double-Mutant Mice Genetics, February 1, 2004; 166(2): 925 - 933. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L.J. Ellacott and R. D. Cone The Central Melanocortin System and the Integration of Short- and Long-term Regulators of Energy Homeostasis Recent Prog. Horm. Res., January 1, 2004; 59(1): 395 - 408. [Abstract] [Full Text] |
||||
![]() |
S. R. Smith, B. Gawronska-Kozak, L. Janderova, T. Nguyen, A. Murrell, J. M. Stephens, and R. L. Mynatt Agouti Expression in Human Adipose Tissue: Functional Consequences and Increased Expression in Type 2 Diabetes Diabetes, December 1, 2003; 52(12): 2914 - 2922. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Mizuno, K. A. Kelley, G. M. Pasinetti, J. L. Roberts, and C. V. Mobbs Transgenic Neuronal Expression of Proopiomelanocortin Attenuates Hyperphagic Response to Fasting and Reverses Metabolic Impairments in Leptin-Deficient Obese Mice Diabetes, November 1, 2003; 52(11): 2675 - 2683. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Butler, J. Janson, W. C. Soeller, and P. C. Butler Increased {beta}-Cell Apoptosis Prevents Adaptive Increase in {beta}-Cell Mass in Mouse Model of Type 2 Diabetes: Evidence for Role of Islet Amyloid Formation Rather Than Direct Action of Amyloid Diabetes, September 1, 2003; 52(9): 2304 - 2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Waterland and R. L. Jirtle Transposable Elements: Targets for Early Nutritional Effects on Epigenetic Gene Regulation Mol. Cell. Biol., August 1, 2003; 23(15): 5293 - 5300. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Marks, A. A. Butler, R. Turner, G. Brookhart, and R. D. Cone Differential Role of Melanocortin Receptor Subtypes in Cachexia Endocrinology, April 1, 2003; 144(4): 1513 - 1523. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Cooney, A. A. Dave, and G. L. Wolff Maternal Methyl Supplements in Mice Affect Epigenetic Variation and DNA Methylation of Offspring J. Nutr., August 1, 2002; 132(8): 2393S - 2400. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tsuruta, H. Yoshimatsu, S. Hidaka, S. Kondou, K. Okamoto, and T. Sakata Hyperleptinemia in Ay/a mice upregulates arcuate cocaine- and amphetamine-regulated transcript expression Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E967 - E973. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Franckhauser, S. Munoz, A. Pujol, A. Casellas, E. Riu, P. Otaegui, B. Su, and F. Bosch Increased Fatty Acid Re-esterification by PEPCK Overexpression in Adipose Tissue Leads to Obesity Without Insulin Resistance Diabetes, March 1, 2002; 51(3): 624 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Majdic, M. Young, E. Gomez-Sanchez, P. Anderson, L. S. Szczepaniak, R. L. Dobbins, J. D. McGarry, and K. L. Parker Knockout Mice Lacking Steroidogenic Factor 1 Are a Novel Genetic Model of Hypothalamic Obesity Endocrinology, February 1, 2002; 143(2): 607 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Miltenberger, K. Wakamatsu, S. Ito, R. P. Woychik, L. B. Russell, and E. J. Michaud Molecular and Phenotypic Analysis of 25 Recessive, Homozygous-Viable Alleles at the Mouse agouti Locus Genetics, February 1, 2002; 160(2): 659 - 674. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Baran, E. Preston, D. Wilks, G. J. Cooney, E. W. Kraegen, and A. Sainsbury Chronic Central Melanocortin-4 Receptor Antagonism and Central Neuropeptide-Y Infusion in Rats Produce Increased Adiposity by Divergent Pathways Diabetes, January 1, 2002; 51(1): 152 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Hani, S. Dupont, E. Durand, C. Dina, S. Gallina, I. Gantz, and P. Froguel Naturally Occurring Mutations in the Melanocortin Receptor 3 Gene Are Not Associated with Type 2 Diabetes Mellitus in French Caucasians J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2895 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Xue and M. B. Zemel Agouti Signaling Protein Stimulates Islet Amyloid Polypeptide (Amylin) Secretion in Pancreatic {beta}-Cells Experimental Biology and Medicine, June 1, 2001; 226(6): 565 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adage, A. J. W. Scheurink, S. F. de Boer, K. de Vries, J. P. Konsman, F. Kuipers, R. A. H. Adan, D. G. Baskin, M. W. Schwartz, and G. van Dijk Hypothalamic, Metabolic, and Behavioral Responses to Pharmacological Inhibition of CNS Melanocortin Signaling in Rats J. Neurosci., May 15, 2001; 21(10): 3639 - 3645. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Mynatt and J. M. Stephens Agouti regulates adipocyte transcription factors Am J Physiol Cell Physiol, April 1, 2001; 280(4): C954 - C961. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Abdel-Malek, M. Scott, M Furumura, M. Lamoreux, M Ollmann, G. Barsh, and V. Hearing The melanocortin 1 receptor is the principal mediator of the effects of agouti signaling protein on mammalian melanocytes J. Cell Sci., January 3, 2001; 114(5): 1019 - 1024. [Abstract] [PDF] |
||||
![]() |
S. Kim and N. Moustaid-Moussa Secretory, Endocrine and Autocrine/Paracrine Function of the Adipocyte J. Nutr., December 1, 2000; 130 (12): 3110S - 3115S. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ste. Marie, G. I. Miura, D. J. Marsh, K. Yagaloff, and R. D. Palmiter A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors PNAS, October 4, 2000; (2000) 220409497. [Abstract] [Full Text] |
||||
![]() |
B. Xue and M. B. Zemel Relationship between Human Adipose Tissue Agouti and Fatty Acid Synthase (FAS) J. Nutr., October 1, 2000; 130(10): 2478 - 2481. [Abstract] [Full Text] |
||||
![]() |
K. J. CLAYCOMBE, Y. WANG, B. H. JONES, S. KIM, W. O. WILKISON, M. B. ZEMEL, J. CHUN, and N. MOUSTAID-MOUSSA Transcriptional regulation of the adipocyte fatty acid synthase gene by agouti: interaction with insulin Physiol Genomics, September 8, 2000; 3(3): 157 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. CLAYCOMBE, B. Z. XUE, R. L. MYNATT, M. B. ZEMEL, and N. MOUSTAID-MOUSSA Regulation of leptin by agouti Physiol Genomics, April 27, 2000; 2(3): 101 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Dinulescu and R. D. Cone Agouti and Agouti-related Protein: Analogies and Contrasts J. Biol. Chem., March 15, 2000; 275(10): 6695 - 6698. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Chen and A. Garg Monogenic disorders of obesity and body fat distribution J. Lipid Res., October 1, 1999; 40(10): 1735 - 1746. [Abstract] [Full Text] |
||||
![]() |
R. J. Miltenberger, R. L. Mynatt, B. D. Bruce, W. O. Wilkison, R. P. Woychik, and E. J. Michaud An agouti mutation lacking the basic domain induces yellow pigmentation but not obesity in transgenic mice PNAS, July 20, 1999; 96(15): 8579 - 8584. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jequier and L. Tappy Regulation of Body Weight in Humans Physiol Rev, April 1, 1999; 79(2): 451 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Haskell-Luevano, P. Chen, C. Li, K. Chang, M. S. Smith, J. L. Cameron, and R. D. Cone Characterization of the Neuroanatomical Distribution of Agouti-Related Protein Immunoreactivity in the Rhesus Monkey and the Rat Endocrinology, March 1, 1999; 140(3): 1408 - 1415. [Abstract] [Full Text] |
||||
![]() |
Q.-H. Huang, V. J. Hruby, and J. B. Tatro Role of central melanocortins in endotoxin-induced anorexia Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R864 - R871. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight Endocr. Rev., February 1, 1999; 20(1): 68 - 100. [Abstract] [Full Text] |
||||
![]() |
B. Xue, N. Moustaid-moussa, W. O. Wilkison, and M. B. Zemel The agouti gene product inhibits lipolysis in human adipocytes via a Ca2+-dependent mechanism FASEB J, October 1, 1998; 12(13): 1391 - 1396. [Abstract] [Full Text] |
||||
![]() |
E. Aberdam, C. Bertolotto, E. V. Sviderskaya, V. de Thillot, T. J. Hemesath, D. E. Fisher, D. C. Bennett, J.-P. Ortonne, and R. Ballotti Involvement of Microphthalmia in the Inhibition of Melanocyte Lineage Differentiation and of Melanogenesis by Agouti Signal Protein J. Biol. Chem., July 31, 1998; 273(31): 19560 - 19565. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Ludwig, K. G. Mountjoy, J. B. Tatro, J. A. Gillette, R. C. Frederich, J. S. Flier, and E. Maratos-Flier Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus Am J Physiol Endocrinol Metab, April 1, 1998; 274(4): E627 - E633. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Leibel, W. K. Chung, and S. C. Chua Jr. The Molecular Genetics of Rodent Single Gene Obesities J. Biol. Chem., December 19, 1997; 272(51): 31937 - 31940. [Full Text] [PDF] |
||||
![]() |
B. A. Boston, K. M. Blaydon, J. Varnerin, and R. D. Cone Independent and Additive Effects of Central POMC and Leptin Pathways on Murine Obesity Science, November 28, 1997; 278(5343): 1641 - 1644. [Abstract] [Full Text] |
||||
![]() |
G. L. Wolff Obesity as a Pleiotropic Effect of Gene Action J. Nutr., September 1, 1997; 127(9): 1897 - 1897. [Abstract] [Full Text] |
||||
![]() |
R. J. Miltenberger, R. L. Mynatt, J. E. Wilkinson, and R. P. Woychik The Role of the agouti Gene in the Yellow Obese Syndrome J. Nutr., September 1, 1997; 127(9): 1902 - 1902. [Abstract] [Full Text] |
||||
![]() |
R. A. Kesterson, D. Huszar, C. A. Lynch, R. B. Simerly, and R. D. Cone Induction of Neuropeptide Y Gene Expression in the Dorsal Medial Hypothalamic Nucleus in Two Models of the Agouti Obesity Syndrome Mol. Endocrinol., May 1, 1997; 11(5): 630 - 637. [Abstract] [Full Text] |
||||
![]() |
R. Ballard-Barbash, D. F. Birt, M. Kestin, and I. B. King Perspectives on Integrating Experimental and Epidemiologic Research on Diet, Anthropometry and Breast Cancer J. Nutr., May 1, 1997; 127 (5): 936S - 936S. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-K. Yang, M. M. Ollmann, B. D. Wilson, C. Dickinson, T. Yamada, G. S. Barsh, and I. Gantz Effects of Recombinant Agouti-Signaling Protein on Melanocortin Action Mol. Endocrinol., March 1, 1997; 11(3): 274 - 280. [Abstract] [Full Text] |
||||
![]() |
R. L. Mynatt, R. J. Miltenberger, M. L. Klebig, M. B. Zemel, J. E. Wilkinson, W. O. Wilkison, and R. P. Woychik Combined effects of insulin treatment and adipose tissue-specific agouti expression on the development of obesity PNAS, February 4, 1997; 94(3): 919 - 922. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ste. Marie, G. I. Miura, D. J. Marsh, K. Yagaloff, and R. D. Palmiter A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors PNAS, October 24, 2000; 97(22): 12339 - 12344. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Z. XUE, W. O. WILKISON, R. L. MYNATT, N. MOUSTAID, M. GOLDMAN, and M. B. ZEMEL The agouti gene product stimulates pancreatic {beta}-cell Ca2+ signaling and insulin release Physiol Genomics, July 15, 1999; 1(1): 11 - 19. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. WOLFF, D. W. ROBERTS, and K. G. MOUNTJOY Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome Physiol Genomics, November 11, 1999; 1(3): 151 - 163. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |